Ahmedabad, India

Venkataramana Naidu

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Venkataramana Naidu: Innovator in Pharmaceutical Compositions

Introduction

Venkataramana Naidu is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable oral compositions. With a total of 2 patents to his name, Naidu's work focuses on improving the stability and efficacy of pharmaceutical formulations.

Latest Patents

One of Naidu's latest patents is for a stable oral composition of cyclophosphamide. This innovative formulation is designed to enhance the stability and palatability of cyclophosphamide, making it suitable for pediatric patients. The composition can be presented in the form of a powder for oral solution, which simplifies reconstitution and improves patient compliance. Additionally, Naidu has developed a non-pulsatile prolonged-release betahistine oral solid composition. This formulation is designed to treat vestibular diseases, including Menière's disease, and provides a controlled release of betahistine over a 24-hour period.

Career Highlights

Venkataramana Naidu is currently associated with Intas Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Intas has allowed him to focus on innovative drug formulations that address specific medical needs.

Collaborations

Naidu has collaborated with several professionals in his field, including Himanshukumar Dasharathlal Patel and Vinod Purushottam Dube. These collaborations have contributed to the advancement of pharmaceutical research and development.

Conclusion

Venkataramana Naidu's contributions to pharmaceutical innovations highlight his commitment to improving patient care through effective drug formulations. His patents reflect a deep understanding of the complexities involved in pharmaceutical development, making him a valuable asset to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…